Stock screener

NEOG

Conviction 69HealthcareScan · Thu, Jun 25, 2026
NEOG$9.51+3.59%
ResistanceSupportVol 14
63 bars
Vol MA14 2.18M
Mar 26Apr 14May 1May 19Jun 8Jun 25
NEOGEN CORPIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.neogen.com
Price9.51
Change+3.59%
Gap+2.02%
Rel volume2.66×
Avg volume2.4M
Avg $ vol21.93M
SMA 209.10
SMA 509.09
SMA 2008.17
Price vs 50+4.61%
Price vs 200+16.45%
MA stackbullish
50/200 cross
Supertrendup · 8.38
RSI (14)57
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D88 / 56
ADX (14)10
+DI / −DI24 / 19
RSI divergence
MACD divergence
ATR %+3.89%
ADR %3.60%
52w high11.33
52w low4.65
From 52w high-16.06%
Above 52w low+104.52%
New 52w highNo
SqueezeOn · 7d
Bollinger width8.99%
%B1.01
Donchian pos89.39%
Donchian high9.62
Donchian low8.63
AVWAP (52w high)9.38
vs AVWAP high+1.35%
AVWAP (52w low)7.37
vs AVWAP low+29.02%
OBV trendFlat
Chaikin MF (20)-0.01
Today vs 20d2.66×
Avg vol (14d)2.18M
Avg vol (20d)2.4M
Avg $ vol (20d)21.93M
Market cap2.07B
RS 3m (vs SPY)-11.49%
RS 6m (vs SPY)+19.76%
RS line new highNo
Trend template7/8
Technical rank81.7
1 week+6.49%
1 month+4.05%
3 months+3.82%
6 months+33.38%
1 year+92.90%
YTD+35.86%
P/E-1.90
P/B0.98
P/S2.31
P/FCF36.48
EPS-5.03
Div yield
ROE-51.94%
ROA-32.51%
Debt/Eq0.39
Current3.92
EV/EBITDA-2.89
Gross margin47.10%
Net margin-122.06%
Rev growth-3.20%
EPS growth
Price target12.00
Target upside26.18%
Analyst ratingBuy
Institutional122.29%
Ent. value2.72B
Revenue211.2M
Net income-17M
Gross profit99M
Free cash flow56.74M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out217.67M
Employees1.46K
ListedWed, Aug 23, 1989
Free float216.74M
Float %99.6%
Short interest13.03M
Days to cover3.6d
Short volume77.2%
Squeeze score65 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.03 · 3 est
Last EPS vs est$0.08 vs $0.02
Last surprise+300.0% beat
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank81.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance9.52
Support8.39
Days since event
Candle confirm
News sentiment

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NEOG

All disclosures →
No recent disclosed trades by Congress in NEOG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NEOG · 4 buys · 5 sells

InsiderSideShares
Moylan John Patrick
Chief Accounting Officer · Restricted Stock Units · 2026-06-03
Tax2.55K
Rocklin Amy M
Former Chief Legal Officer · Common Stock · 2026-05-18
Exercise35.18K
Rocklin Amy M
Former Chief Legal Officer · Restricted Stock Units · 2026-05-18
Exercise35.18K
Rocklin Amy M
Former Chief Legal Officer · Common Stock · 2026-05-18
Tax10.24K
Moylan John Patrick
Chief Accounting Officer · Restricted Stock Units · 2026-05-04
Exercise4.56K
Moylan John Patrick
Chief Accounting Officer · Common Stock · 2026-05-04
Tax1.57K
Moylan John Patrick
Chief Accounting Officer · Common Stock · 2026-05-04
Exercise4.56K
Stacey Jennifer Evans
Chief Legal Officer · Common Stock · 2026-05-01
Grant39.35K
Stacey Jennifer Evans
Chief Legal Officer · Common Stock (Right to Buy) · 2026-05-01
Grant89.52K

SEC filings

EDGAR filings in NEOG · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.